SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

9529	Companies
187479	Keywords
119514	Articles
100217	Press releases

Home
Companies
SANOFI-AVENTIS

BRIEF

published on 12/15/2025 at 07:10, 12 hours ago

Sanofi: PERSEUS study results on tolebrutinib disappointing

Study Results Multiple Sclerosis Sanofi Tolebrutinib PERSEUS Study
BRIEF

published on 12/15/2025 at 07:10, 12 hours ago

Sanofi Halts Pursuit of Regulatory Registration for Tolebrutinib in PPMS

Multiple Sclerosis Tolebrutinib PPMS Trial PERSEUS Study Sanofi R&D
PRESS RELEASE

published on 12/15/2025 at 07:05, 12 hours 5 minutes ago

Press Release: Sanofi provides update on tolebrutinib in primary progressive multiple sclerosis
Sanofi updates on tolebrutinib in primary progressive multiple sclerosis, PERSEUS phase 3 study did not meet primary endpoint. Safety profile consistent. Financial impacts discussed

Sanofi Tolebrutinib Primary Progressive Multiple Sclerosis PERSEUS Phase 3 Study Financial Considerations
BRIEF

published on 12/15/2025 at 07:05, 12 hours 5 minutes ago

Sanofi's Tolebrutinib Regulatory Submission Delayed

FDA Multiple Sclerosis Sanofi Tolebrutinib Regulatory Delay
PRESS RELEASE

published on 12/15/2025 at 07:00, 12 hours 10 minutes ago

Press Release : Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
Sanofi anticipates a delay in tolebrutinib regulatory decision for nrSPMS, with ongoing discussions with the FDA. An expanded access protocol has been submitted for eligible patients

FDA Sanofi Tolebrutinib Regulatory Submission NrSPMS
BRIEF

published on 12/11/2025 at 07:05, 4 days 12 hours ago

Sanofi obtains approval in China for Qfitlia and Cablivi

China Sanofi Rare Diseases Qfitlia Cablivi
BRIEF

published on 12/11/2025 at 07:05, 4 days 12 hours ago

Sanofi's Breakthrough in China with Qfitlia and Cablivi Approvals

Sanofi Rare Diseases Qfitlia Cablivi China Approvals
PRESS RELEASE

published on 12/11/2025 at 07:00, 4 days 12 hours ago

Press Release: Sanofi’s Qfitlia and Cablivi approved in China, expanding care for rare diseases
Sanofi's Qfitlia and Cablivi have been approved in China by the National Medical Products Administration, expanding care for rare diseases in the country. Qfitlia offers protection for hemophilia with as few as six injections a year, while Cablivi targets a rare life-threatening blood clotting disorder

China Sanofi Rare Diseases Qfitlia Cablivi
BRIEF

published on 12/04/2025 at 11:05, 11 days 8 hours ago

Sanofi Completes Acquisition of Vicebio

Respiratory Viruses Sanofi Acquisition Molecular Clamp Vicebio Vaccine Vaccine Pipeline
PRESS RELEASE

published on 12/04/2025 at 11:00, 11 days 8 hours ago

Press Release: Sanofi completes acquisition of Vicebio
Sanofi completes acquisition of Vicebio, enhancing its vaccine portfolio with a combination vaccine candidate for RSV and HMPV. The 'Molecular Clamp' technology expands vaccine design capabilities

Acquisition Sanofi Vaccine Candidate RSV Vicebio

Accesswire

Published on 12/15/2025 at 18:15, 55 minutes ago

Athena Gold Closes Second Tranche of Non-brokered Private Placement and Increases Offering Due to Strong Demand
Published on 12/15/2025 at 16:35, 2 hours 35 minutes ago

Stillwater Critical Minerals Announces Upsize of Bought Deal LIFE Private Placement for Gross Proceeds of C$15 Million
Published on 12/15/2025 at 15:00, 4 hours 10 minutes ago

Kingfisher Reports Annual General Meeting Voting Results
Published on 12/15/2025 at 15:00, 4 hours 10 minutes ago

Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
Published on 12/15/2025 at 14:30, 4 hours 40 minutes ago

Unusual Machines Congratulates Customers Selected for the Army's PBAS Tranche 1.1, Including Envision Technology and Strategic Logix

View all ACCESSWIRE

EQS Group

Published on 12/15/2025 at 18:15, 55 minutes ago

Results of EQT’s mandatory simplified cash tender offer for Waga Energy’s remaining shares
Published on 12/15/2025 at 18:07, 1 hour 2 minutes ago

POS-Transaction in Own Shares
Published on 12/15/2025 at 18:00, 1 hour 10 minutes ago

LIGHTON: Adjustment of ARR target for FY 2025
Published on 12/15/2025 at 17:45, 1 hour 25 minutes ago

EQS-Adhoc: Airbus SE: Airbus reports share buybacks for week starting 8 December 2025
Published on 12/15/2025 at 17:38, 1 hour 31 minutes ago

Stabilus SE approves share buyback program with a volume of up to €20 million

Les Echos

Published on 12/15/2025 at 18:30, 40 minutes ago

MCH PRIVATE EQUITY AND EURAZEO ENTER INTO AN EXCLUSIVE AGREEMENT WITH ARDIAN FOR THE SALE OF THEIR MAJORITY STAKE IN FERMAX
Published on 12/15/2025 at 18:05, 1 hour 5 minutes ago

Covivio - Treasury shares transactions between December 8th , 2025 and December 12th, 2025
Published on 12/15/2025 at 17:45, 1 hour 24 minutes ago

ENGIE strengthens the resilience of the Belgian electricity system with new flexible capacities
Published on 12/15/2025 at 17:40, 1 hour 30 minutes ago

LISI joins the SBF 120 and CAC Mid 60 indices
Published on 12/15/2025 at 17:35, 1 hour 35 minutes ago

DISCLOSURE OF TRANSACTIONS IN OWN SHARES FROM DECEMBER 8 TO DECEMBER 12, 2025

View all LES ECHOS COMFI WIRE